Search Results - "Gorelick, David"

Refine Results
  1. 1

    Cannabis-Related Disorders and Toxic Effects by Gorelick, David A.

    Published in The New England journal of medicine (14-12-2023)
    “…Heavy cannabis use has adverse effects on physical and mental health. Research is needed to better elucidate the pathophysiology of these effects and develop…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Kratom: Substance of Abuse or Therapeutic Plant? by Gorelick, David A.

    Published in The Psychiatric clinics of North America (01-09-2022)
    “…Kratom is the common term for Mitragyna speciosa and its products. Its major active compounds are mitragynine and 7-hydroxymitragynine. An estimated 2.1…”
    Get full text
    Journal Article
  4. 4

    Transcranial magnetic stimulation in the treatment of substance addiction by Gorelick, David A., Zangen, Abraham, George, Mark S.

    Published in Annals of the New York Academy of Sciences (01-10-2014)
    “…Transcranial magnetic stimulation (TMS) is a noninvasive method of brain stimulation used to treat a variety of neuropsychiatric disorders, but is still in the…”
    Get full text
    Journal Article
  5. 5

    Synthetic cannabinoids: Epidemiology, pharmacodynamics, and clinical implications by Castaneto, Marisol S, Gorelick, David A, Desrosiers, Nathalie A, Hartman, Rebecca L, Pirard, Sandrine, Huestis, Marilyn A

    Published in Drug and alcohol dependence (01-11-2014)
    “…Abstract Background Synthetic cannabinoids (SC) are a heterogeneous group of compounds developed to probe the endogenous cannabinoid system or as potential…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Pharmacological Treatment of Cannabis-Related Disorders: A Narrative Review by Gorelick, David A

    Published in Current pharmaceutical design (01-01-2016)
    “…Cannabis is the most widely used illicit psychoactive substance world-wide, yet no medication is approved for the treatment of intoxication, withdrawal, or…”
    Get more information
    Journal Article
  8. 8

    Introduction to Behavioral Addictions by Grant, Jon E., Potenza, Marc N., Weinstein, Aviv, Gorelick, David A.

    “…Background: Several behaviors, besides psychoactive substance ingestion, produce short-term reward that may engender persistent behavior, despite knowledge of…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Smoked Cannabis' Psychomotor and Neurocognitive Effects in Occasional and Frequent Smokers by Desrosiers, Nathalie A., Ramaekers, Johannes G., Chauchard, Emeline, Gorelick, David A., Huestis, Marilyn A.

    Published in Journal of analytical toxicology (01-05-2015)
    “…Δ9-Tetrahydrocannabinol (THC), the primary psychoactive constituent in cannabis, impairs psychomotor performance, cognition and driving ability; thus, driving…”
    Get full text
    Journal Article
  11. 11

    Controlled Cannabis Vaporizer Administration: Blood and Plasma Cannabinoids with and without Alcohol by Hartman, Rebecca L, Brown, Timothy L, Milavetz, Gary, Spurgin, Andrew, Gorelick, David A, Gaffney, Gary, Huestis, Marilyn A

    Published in Clinical chemistry (Baltimore, Md.) (01-06-2015)
    “…Increased medical and legal cannabis intake is accompanied by greater use of cannabis vaporization and more cases of driving under the influence of cannabis…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Pharmacological treatment of cannabis dependence by Weinstein, A M, Gorelick, David A

    Published in Current pharmaceutical design (01-05-2011)
    “…Cannabis is the most frequently used illegal psychoactive substance in the world. There is a significant increase in the number of treatment admissions for…”
    Get more information
    Journal Article
  14. 14

    Identification of Recent Cannabis Use: Whole-Blood and Plasma Free and Glucuronidated Cannabinoid Pharmacokinetics following Controlled Smoked Cannabis Administration by SCHWOPE, David M, KARSCHNER, Erin L, GORELICK, David A, HUESTIS, Marilyn A

    Published in Clinical chemistry (Baltimore, Md.) (01-10-2011)
    “…Δ⁹-Tetrahydrocannabinol (THC) is the most frequently observed illicit drug in investigations of accidents and driving under the influence of drugs…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17

    Advancing Regional Water Supply Management and Infrastructure Investment Pathways That Are Equitable, Robust, Adaptive, and Cooperatively Stable by Gold, David F., Reed, Patrick M., Gorelick, David E., Characklis, Gregory W.

    Published in Water resources research (01-09-2023)
    “…Abstract Regionalization approaches—where utilities in close geographic proximity cooperate to manage drought risks and co‐invest in new infrastructure—are…”
    Get full text
    Journal Article
  18. 18

    A randomized, double‐blind, placebo‐controlled, pharmacogenetic study of ondansetron for treating alcohol use disorder by Seneviratne, Chamindi, Gorelick, David A., Lynch, Kevin G., Brown, Clayton, Romer, Danielle, Pond, Timothy, Kampman, Kyle, Kranzler, Henry R.

    “…Background In a previous study, ondansetron, a serotonin 5‐HT3 receptor antagonist, reduced drinking intensity (drinks/drinking day [DPDD]) among…”
    Get full text
    Journal Article
  19. 19

    State of the Art Treatments for Cannabis Dependence by Danovitch, Itai, MD, Gorelick, David A., MD, PhD, DFAPA

    Published in The Psychiatric clinics of North America (01-06-2012)
    “…The treatment of cannabis dependence can be viewed as a cup half empty or half full. On the one hand, few people who might benefit from treatment actually…”
    Get full text
    Journal Article
  20. 20

    The future of endocannabinoid-oriented clinical research after CB1 antagonists by Le Foll, Bernard, Gorelick, David A., Goldberg, Steven R.

    Published in Psychopharmacology (01-07-2009)
    “…Introduction Great interest has been shown by the medical community and the public in the cannabinoid CB 1 receptor antagonists, such as rimonabant, for…”
    Get full text
    Journal Article